FDA Inspection 1267970 — Sosana Delimpasi, M.D.
The FDA completed an inspection of Sosana Delimpasi, M.D. on March 7, 2025 in Athens. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Athens (Greece)
Additional Details
Clinical Investigator (CI)